Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Autoimmune Diseases

lenalidomide has been researched along with Autoimmune Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Ahlgrimm, M; Bewarder, M; Bittenbring, JT; Brill, K; Cetin, O; Christofyllakis, K; Kaddu-Mulindwa, D; Kiefer, M; Kos, IA; Lohse, S; Neumann, F; Smola, S; Thurner, L1
Boulard, C; Courville, P; Gremain, V; Langlois, V; Litrowski, N; Marguet, F; Zarnitsky, C1
Kaiser, T; Metze, M; Petros, S; Pfrepper, C; Pierer, M; Poenisch, W1
Buadi, FK; Gertz, MA1
Bonini, C; Caprioli, C; Cocito, F; Corradini, P; Dalto, S; De Philippis, C; Dodero, A; Farina, L; Galli, M; Maura, F; Montefusco, V; Mussetti, A; Pennisi, M; Perrone, G; Rezzonico, F; Roncari, L; Soldarini, M; Spina, F; Stefanoni, P1
Al Ali, NH; Bart-Smith, E; Craig, BM; Epling-Burnette, PK; Komrokji, RS; Kordasti, S; Kulasekararaj, A; Lancet, JE; List, AF; Mufti, GJ; Padron, E; Pinilla-Ibarz, J; Zhang, L1

Other Studies

6 other study(ies) available for lenalidomide and Autoimmune Diseases

ArticleYear
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2.
    Expert review of vaccines, 2022, Volume: 21, Issue:11

    Topics: Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; Immunity, Humoral; Immunosuppression Therapy; Lenalidomide; Neoplasms; SARS-CoV-2; Tumor Necrosis Factor Inhibitors

2022
Necrotizing autoimmune myopathy associated with POEMS syndrome report.
    QJM : monthly journal of the Association of Physicians, 2018, Jan-01, Volume: 111, Issue:1

    Topics: Autoimmune Diseases; Dexamethasone; Electromyography; Humans; Lenalidomide; Male; Middle Aged; Muscular Diseases; POEMS Syndrome; Thalidomide

2018
Inhibitor eradication in refractory acquired hemophilia with lenalidomide.
    Annals of hematology, 2019, Volume: 98, Issue:6

    Topics: Autoantibodies; Autoimmune Diseases; Drug Eruptions; Drug Substitution; Factor VIII; Hemophilia A; Hemorrhage; Humans; Immunosuppressive Agents; Lenalidomide; Male; Middle Aged; Paraplegia; Spinal Cord

2019
Potential new risks of lenalidomide.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:9

    Topics: Autoimmune Diseases; Humans; Immunologic Factors; Lenalidomide; Male; Multiple Myeloma; Thalidomide

2014
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Retrospective Studies; Thalidomide; Treatment Outcome

2014
Autoimmune diseases and myelodysplastic syndromes.
    American journal of hematology, 2016, Volume: 91, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azacitidine; Comorbidity; Disease Progression; Disease Susceptibility; Female; Follow-Up Studies; Hashimoto Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Kaplan-Meier Estimate; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Prevalence; Proportional Hazards Models; Retrospective Studies; Thalidomide; Thyroiditis, Autoimmune; Young Adult

2016